Drug Shortage Report for SOLYSTAT
| Report ID | 213439 |
| Drug Identification Number | 00755338 |
| Brand name | SOLYSTAT |
| Common or Proper name | SOLYSTAT |
| Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
| Strength(s) | 1G |
| Dosage form(s) | POWDER FOR SUSPENSION POWDER |
| Route of administration | RECTAL ORAL RECTAL ORAL |
| Packaging size | 454g |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-12-22 |
| Actual start date | 2023-12-20 |
| Estimated end date | 2024-04-01 |
| Actual end date | 2024-03-21 |
| Shortage status | Resolved |
| Updated date | 2024-03-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v14 | 2024-03-22 | English | Compare |
| v13 | 2024-03-21 | French | Compare |
| v12 | 2024-03-21 | English | Compare |
| v11 | 2024-03-05 | French | Compare |
| v10 | 2024-03-05 | English | Compare |
| v9 | 2024-03-05 | French | Compare |
| v8 | 2024-03-05 | English | Compare |
| v7 | 2024-02-19 | French | Compare |
| v6 | 2024-02-19 | English | Compare |
| v5 | 2023-12-21 | English | Compare |
| v4 | 2023-12-19 | French | Compare |
| v3 | 2023-12-19 | English | Compare |
| v2 | 2023-12-15 | French | Compare |
| v1 | 2023-12-15 | English | Compare |
Showing 1 to 14 of 14